Accès gratuit
Numéro |
Med Sci (Paris)
Volume 39, Novembre 2023
Les Cahiers de Myologie
|
|
---|---|---|
Page(s) | 58 - 63 | |
Section | Cas clinique | |
DOI | https://doi.org/10.1051/medsci/2023135 | |
Publié en ligne | 17 novembre 2023 |
- Ohno K, Ohkawara B, Shen XM et al. Clinical and apthologic features of congenital myasthenic syndromes caused by 35 genes. A comprehensive review. Int J Mol Sci 2023; 24 : 3730. [CrossRef] [PubMed] [Google Scholar]
- Richard P, Gaudon K, Haddad H, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa. Neurology 2008 ; 71 : 1967–1972. [CrossRef] [PubMed] [Google Scholar]
- Rodríguez Cruz PM. Palace J, Beeson D. Inherited disorders of the neuromuscular junction: an update. J Neurol 2014 ; 261 : 2234–2243. [CrossRef] [PubMed] [Google Scholar]
- Gomez CM, Maselli R, Staub J, et al. Novel delta and beta subunit acetylcholine receptor mutations in the slow-channel syndrome demonstrate phenotypic variability. Soc Neurosci Abstr 1998 ; 24 : 284. [Google Scholar]
- Finlayson S, Spillane J, Kullmann DM, et al. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol. Muscle Nerve 2013 ; 47 : 279–282. [CrossRef] [PubMed] [Google Scholar]
- Chaouch A, Müller JS, Guergueltcheva V, et al. A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J Neurol 2012 ; 259 : 474–481. [CrossRef] [PubMed] [Google Scholar]
- Gomez CM, Maselli RA, Vohra BP, et al. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms. Ann Neurol 2002 ; 51 : 102–112. [CrossRef] [PubMed] [Google Scholar]
- Croxen R, Hatton C, Shelley C, et al. Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 2002 ; 72 : 294. [Google Scholar]
- Ohno K, Wang HL, Milone M, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron 1996 ; 17 : 157–170. [CrossRef] [PubMed] [Google Scholar]
- Wang HL, Milone M, Ohno K, et al.. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci, 1999 2: 226–33. Erratum in Nat Neurosci 1999 ; 2 : 485. [CrossRef] [PubMed] [Google Scholar]
- Shen XM, Brengman JM, Edvardson S, et al. Highly fatal fast-channel syndrome caused by AChR ε subunit mutation at the agonist binding site. Neurology 2012 ; 79 : 449–454. [CrossRef] [PubMed] [Google Scholar]
- Palace J, Lashley D, Bailey S, et al. Clinical features in a series of fast channel congenital myasthenia syndrome. Neuromuscul Disord 2012 ; 22 : 112–117. [CrossRef] [PubMed] [Google Scholar]
- Heckmann JM, Morrison KE, Emeryk-Szajewska B, et al. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimmun 1996 ; 9 : 175–180. [CrossRef] [PubMed] [Google Scholar]
- Giraud M, Eymard B, Tranchant C, et al. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis. Genes Immun 2004 ; 5 : 80–83. [CrossRef] [PubMed] [Google Scholar]
- Santos E, Moreira I, Coutinho E, et al. Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis. Neuromuscul Disord 2015 ; 25 : 928–931. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.